SpecificationsOrganism/cell line/tissueMus musculusSexMaleSequencer or array typeAgilent SurePrint G3 mouse gene expression 8 × 60 k arraysData formatRaw and analysedExperimental factorsCultured tail and heart fibroblastsExperimental featuresExperiment comparing expression profile of mouse tail and cardiac fibroblasts in adult wild-type animalsConsentAll animal experimentation conformed with local (Monash University) and national guidelines in Australia, under breeding ethics license MARP/2011/038/BC and experimental license MARP/2011/175Sample source locationMonash Animal Services (MAS), Melbourne, Australia (originally imported from The Jackson Laboratory, Maine, USA)

Direct link to deposited data {#s0010}
=============================

Deposited data can be found here: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50531>.

Experimental design, materials and methods {#s0015}
==========================================

Mouse usage {#s0020}
-----------

Eight-week old C57Bl/6J (<http://jaxmice.jax.org/strain/000664.html>) adult male mice were obtained from Monash Animal Services (MAS) facility, Monash University.

Fibroblast isolation and culture {#s0025}
--------------------------------

Animals were humanely killed using CO~2~ asphyxiation and hearts were perfused with 20 ml of Hank\'s Balanced Salt Solution without calcium or magnesium (HBSS-Gibco) using a 20 ml syringe and 26 gauge needles. For perfusion, the needle was inserted into the left ventricular chamber, while the right atrial appendage was cut open to allow blood/buffer exit through the pulmonary circulation. This procedure removed excess blood from heart chambers. Prior to cell isolation, two wild-type mouse hearts per sample were finely minced using surgical scissors. Whole tails from the same animals were skinned and cut into 2--3 mm pieces. Both tissues were subjected to enzymatic digestion with 0.05% trypsin/EDTA (Gibco) at 37 °C under agitation for 40 min, washed in HBSS, cleared using 40 μm cell strainers for Falcon tubes (BD Biosciences) that retain undigested tissue, spun at 400 g for 5 min, resuspended in cell culture media \[DMEM high glucose with glutamax (Gibco), supplemented with 10% foetal bovine serum (FBS-Gibco), 1× penicillin/streptomycin (Gibco) and 1 × sodium pyruvate (Gibco)\] and plated on 10 cm dishes (BD Biosciences). Next morning, plates were washed twice in phosphate buffered saline (PBS) without calcium or magnesium (Gibco) to remove debris. Media changes were performed every couple of days until day 5, after which cells were processed for RNA extraction. Cells were cultured in a humidified incubator with 5% CO~2~ at 37 °C.

RNA preparation {#s0030}
---------------

Cultured fibroblasts from heart and tail were processed for total RNA extraction using the mirVana kit (Ambion) as per manufacturer \'s instructions. Briefly, 10 cm dishes containing heart or tail fibroblasts were washed twice in PBS (Gibco) and 500 μl of RNA lysis solution was added to dishes. Cell scrapers (BD Biosciences) were used to homogenise cell disruption, after which 1:10 (v/v) of miRNA homogenate additive was added. Samples were subjected to organic extraction using acid phenol:chloroform and 1.25 volume of ethanol was added to aqueous phases, which were passed through a filter cartridge, washed in kit wash solutions 1 and 2 and eluted in 50 μl of pre-heated (95 °C) elution solution. Following manufacturer\'s recommendations for total RNA recovery, we have not enriched samples for small RNAs. All samples were DNAse digested using DNAseI from the DNA-free kit (Ambion) for 20 min at 37 °C, after which 1:10 (v/v) DNAse inactivation reagent was added, mixed for 2 min at room temperature and spun down at maximum speed for 90 s in an Eppendorf centrifuge to pellet inactivation beads. Samples were transferred into clean tubes and further processed at the Medical Genomics Facility.

Microarray study design {#s0035}
-----------------------

Three replicate samples were profiled per condition (i.e. heart or tail fibroblasts).

RNA labelling and hybridization {#s0040}
-------------------------------

Total RNA from 6 samples (3 tail and 3 heart replicas) was used for microarray analysis. All samples showed RNA integrity numbers (RINs) ranging between 9--10, as determined by the 2100 Bioanalyser (Agilent) ([Fig. 1](#f0005){ref-type="fig"}). 0.1 μg of total RNA was used to prepare Cyanine-3 (Cy3) labelled cRNA for hybridization. For labelling, the One-Color Low input Quick Amp labelling Kit (Agilent) was used according to the manufacturer\'s instructions, after which labelled RNA was cleaned using by RNeasy column purification (Qiagen). Dye incorporation and cRNA yield were determined with the NanoDrop ND-1000 Spectrophotometer.

For chip hybridization, 600 ng of Cy3 labelled cRNAs were fragmented at 60 °C for 30 min in a reaction volume of 25 μl containing 1× Agilent Fragmentation buffer and 2 × Agilent Gene Expression Blocking agent. Specific activities ranging between 16--18 pmol Cy3/μg cRNA were used for each sample. On completion, 25 μl of 2 × HI-RPM Gene Expression buffer (Agilent) was added. 40 μl of samples were hybridised on SurePrint G3 Mouse GE 8 × 60 K microarrays (Agilent) for 17 h at 65 °C in a rotating hybridisation oven (Agilent). Following hybridisation, microarrays were washed with GE wash buffer 1 (Agilent) for 1 min at room temperature and with GE wash buffer 2 at 37 °C for 1 min. Microarrays were scanned with an Agilent C, DNA microarray scanner at 3 μm resolution (scan area 61 × 21.6 mm), dye channel set to green, 20 bit tiff. The scanned images were analysed with Agilent Feature Extraction Software 11.0.1.1 to obtain background subtracted and spatially detrended Processed Signal intensities.

Data normalisation and analysis {#s0045}
-------------------------------

Samples were processed by the Monash Health Translation Precinct (MHTP) Medical Genomics Facility, and run on Agilent SurePrint G3 mouse gene expression arrays (single colour), followed by analysis with GeneSpring 12.6, using quantile normalisation with no baseline transformation, logbase 2. Unpaired T test (p \< = 0.05, logFC \> = 2.0) with Benjamini--Hochberg correction was used to find differentially expressed genes. These results have been reported in the original article [@bb0045].

For the purpose of improved accessibility, a similar analysis was performed here using an open-source pipeline with R and Bioconductor. The raw single-channel signals were extracted with Agilent Feature Extraction Software 11.0.1.1. Non-uniform, saturated probes, and population outliers were filtered using the default "Compromised" option in GeneSpring GX12.6 (Agilent), with threshold raw signal of 1.0. At the end of this process, 6 text files (.txt) were exported for the data normalisation stage. This analysis has been deposited in GEO under the accession number (to be allocated by GEO) and is linked to the original samples GSM1220786-91 under accession number GSE50531.

Data normalisation was performed with R (<http://www.r-project.org>) using the publicly available Bioconductor packages (bioconductor.org) [@bb0050]. Three pre-processing and normalisation steps were performed: (1) use *read*.*maimage* function to extract the *gProcesedSignal* values from the GeneSpring exported data files ([Fig. 2](#f0010){ref-type="fig"}A); (2) use *avereps*.*EList* function to average the duplicate spots and log-2 transformation ([Fig. 2](#f0010){ref-type="fig"}B); and (3) use *normalizeBetweenArrays* function to perform quantile normalisation on all arrays ([Fig. 2](#f0010){ref-type="fig"}C).

Differential analysis between cardiac fibroblast and tail fibroblast samples was performed using the Bioconductor limma package [@bb0055], which applies linear models and differential expression functions to the transcriptomic data. With 6 normalised arrays having identical distributions ([Fig. 2](#f0010){ref-type="fig"}C), the *lmFit* function identifies the genes that have differential expression between 3 cardiac fibroblast samples and 3 tail fibroblast samples. At a p-value threshold of 0.05, we identified a pool of 3924 differentially expressed entities ([Fig. 2](#f0010){ref-type="fig"}D). These entities were used for fold-change calculation ([Fig. 2](#f0010){ref-type="fig"}E), revealing 94 strongly up-regulated entities (16×) and 56 strongly down-regulated entities (− 16 ×). [Table 1.1](#t0005){ref-type="table"}, [Table 1.2](#t0010){ref-type="table"} detailed the gene symbols corresponding to the strongly up- and down-regulated entities, which revealed many cardiogenic genes, including *Tcf21*, *Tbx20* and *Gata4*. The R code to reproduce this analysis is available in GEO.

Discussion {#s0005}
==========

Our goal for the current experiment was to identify cardiac fibroblast-specific genes [@bb0005], [@bb0010], [@bb0015], [@bb0020], [@bb0025], [@bb0030], [@bb0035], [@bb0040]. For this purpose, isolated cells were cultured for 5 days in order to remove carry-over of debris and DNA/RNA from dead cardiomyocytes present in fresh preparations. Contamination with cardiomyocyte structural markers has been reported in previous analyses [@bb0065], as the cell isolation method for compact tissue requires harsh enzymatic dissociation conditions, which causes extensive cardiomyocyte death. We found that a 5-day passage 0 culture produces non-confluent, highly healthy cells where no statistically significant contamination with cardiomyocyte genes can be detected.

Upon visualisation of the raw data ([Fig. 2](#f0010){ref-type="fig"}A), we noticed that sample Tail2 showed higher overall signal intensity than others. As all samples were processed simultaneously and showed similar RIN scores ([Fig. 1](#f0005){ref-type="fig"}), we believe this finding is a technical problem inherent to the hybridization step or chip composition. Nevertheless, this discrepancy did not impair our analysis.

As with many microarray datasets, data noise is an important issue. We performed differential analysis using the robust *lmFit* method, which is widely regarded as noise-tolerant in the bioinformatics community. The high-confidence entities evaluated by log fold-change and p-value (such as the cardiogenic genes *Tcf21* and *Tbx20*) were subsequently validated using qPCR validation to confirm their biological relevance, as described by our main research article [@bb0045].

The microarray analysis pipeline described here made use of both the proprietary GeneSpring GX12.6 software and open source R packages. In addition to our original analysis [@bb0045], we have provided a second open-source analysis to facilitate the reproducibility of our study. Due to differences between methods (algorithms) provided by limma and GeneSpring, and the closed-nature of the Genespring software, there are discrepancies between the final fold-change calculations between the two analyses. However, although the exact values differed for entities found up- and down-regulated in the open source analysis, our genes of interest were similarly differentially regulated in both analyses.

A range of bona fide haematopoietic genes were up-regulated in heart samples, for example *Ccl19*, *Cd28*, *Mpeg1*, *Plac8* and *Cx3cr1*, while other haematopoietic markers, such as *Cd45*, *Cd31 and Cd34* were not significantly altered. Most of these genes have not been correlated with fibroblast biology yet, although expression of *Cx3cr1* has been previously reported in cardiac fibroblasts [@bb0060]. We have also not detected significant levels of CD31, CD34 or CD45 protein in our samples [@bb0045], supporting the argument that if present, haematopoietic cells are not a major contaminant in our cultures. However, leukocyte contamination in our cultures cannot be ruled out at this point. As our laboratory has previously characterised a population of resident macrophages in the heart [@bb0065], follow-up experiments using sorted CD90^+^, CD45^+^, CD31^−^ cells would clarify this issue.
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Appendix A. Supplementary data {#s0060}
==============================

Supplementary R script to reproduce data normalisation results.

We acknowledge the use of facilities Monash Animal Services (MAS) and MHTP Medical Genomics Facility.

Supplementary data to this article can be found online at [http://dx.doi.org/10.1016/j.gdata.2014.10.006](10.1016/j.gdata.2014.10.006){#ir0035}.

![Quality control (QC) analysis for samples used for microarray. A. Electropherogram shows typical plot for high quality total RNA, peaks for 18 s and 28 s ribosomal RNA subunits can be clearly seen for all samples and no intermediate peaks, equivalent to degradation products, are observed. B. Gel image showing expected migration pattern for intact RNA on tail and heart samples, highlighting 18 s (below 2000 bp band of ladder) and 28 s (below 4000 bp band of ladder) ribosomal RNA. Small peaks 25 and 200 nucleotides correspond to the loading marker and small RNAs, respectively. RNA Integrity Number (RIN) scores vary from a minimum of 0 (degraded) to a maximum of 10 (intact) total RNA. nt --- nucleotide; FU --- fluorescence intensity.](gr1){#f0005}

![Normalisation and transcriptome-wide comparison between cardiac fibroblasts and tail fibroblasts. (A --C) Box-plots of the gene expression data at the end of each pre-processing and normalisation processing stage: (A) Single-channel signals extracted from Agilent Feature Extraction Software; (B) data pre-processing, duplicates averaging and log-2 transformation; and (C) quantile normalisation. After normalisation, all samples have identical distributions. (D) Venn diagram illustrating the initial number of entities in the raw data (62,976 genes), the reduction of data points through processing and normalisation (55,821 genes), and finally the pool of differentially-expressed entities with p-value \< 0.05 (3924 genes). (E) Distribution of the level of gene expression fold-changes within the pool of 3924 differentially-expressed entities.](gr2){#f0010}

###### 

List of differentially expressed entities when comparing cardiac fibroblasts to tail fibroblasts (up-regulated, fold change \> 16×, p \< 0.05).

  Probe 1 0        Gene symbol   Log fold change   p-Value      Probe 1 0        Gene symbol   Log fold change   p-Value
  ---------------- ------------- ----------------- ------------ ---------------- ------------- ----------------- ------------
  A_51_P459944     Tcf21         7.774715027       1.38E-07     A_51_P215475     Ptprb         4.720490634       0.00037027
  A_51_P255699     Mmp3          7.668280653       1.93E-05     A_52_P145415     Ptch2         4.695570013       5.40E-06
  A_55_P1982291    Clcal         7.533997026       0.00012796   A_66_P136813     6030408B16R   4.683599203       0.00010558
  A_52_P58145      Aldh1a2       7.293188199       2.35E-07     A_55_P1982404    Gpm6b         4.641949565       0.00142493
  A_51_P265806     Clca2         7.201895798       3.98E-05     A_55_P2108012    Fam78b        4.616958484       6.96E-05
  A_52_P429876     Tbx20         7.199004006       1.04E-06     A_55_P1962305    Plac8         4.595679816       0.00118151
  A_52_P579531     Pdlim3        6.798017108       3.01E-06     A_52_P266132     Fgl2          4.584599456       0.00088425
  A_55_P2111302    Cp            6.728089433       1.49E-06     A_55_P2088720                  4.54706191        2.21E-05
  A_51_P419637     Dclk3         6.63184125        1.94E-07     A_55_P2109585    Plekha7       4.539532165       1.74E-06
  A_55_P2017418    Cfh           6.541868044       4.38E-05     A_55_P2102769    Abca8a        4.535543021       0.00205118
  A_55_P2028894    Gata4         6.490939109       9.05E-05     A_55_P2007495                  4.513579208       4.12E-05
  A_55_P2108248    Art4          6.471910595       0.00010405   A_55_P2029746                  4.492855257       1.38E-05
  A_51_P110301     C3            6.32871005        0.00039752   A_55_P2051596                  4.477946264       0.0002982
  A_55_P1970385                  6.286227697       3.22E-05     A_51_P468140     Serpind1      4.47050946        0.00126139
  A_52_P614777     Sucnr1        6.074222864       0.00026042   A_51_P301998     Fmo2          4.458776979       6.63E-06
  A_55_P2162503    Tbx20         6.001391067       0.00017203   A_55_P1974845    Pde1a         4.457633544       3.85E-06
  A_55_P1992049    Gucy1a3       5.982102699       0.00028777   A_55_P2169356                  4.456953685       0.00467752
  A_51_P127297     Hsd11b1       5.953520453       5.85E-07     A_55_P1953846    Abca8b        4.450698252       0.00092446
  A_51_P159453     Serpina3n     5.799342267       0.00145534   A_55_P1954724    Gm20186       4.412602719       1.39E-05
  A_52_P28960      Gdf6          5.688645717       1.73E-06     A_55_P2153783    Fmo1          4.408916363       2.90E-06
  A_55_P2036240                  5.673154478       4.05E-05     A_52_P179068     Gucy1b3       4.403895518       0.00191671
  A_51_P286748     Frzb          5.607110137       4.68E-05     A_55_P1957213    3930401B19R   4.398861887       1.74E-05
  A_51_P116651     Opt           5.603519237       0.00067503   A_55_P2026270    Cfi           4.390561823       0.00108725
  A_55_P2054854    Art4          5.570955142       0.00336205   A_55_P2140212                  4.366229602       2.05E-05
  A_55_P2038525    C3            5.499803595       5.12E-05     A_55_P2017347    Krtap11--1    4.326344638       0.00387402
  A_55_P2124461                  5.433866138       3.25E-06     A_55_P2114318                  4.31693497        2.77E-05
  A_51_P376445     Rhox5         5.334853046       0.00452163   A_55_P2026547    Gal3st2       4.287884906       0.0001618
  A_55_P2059010    Rbp1          5.268991948       2.76E-06     A_55_P2162910    Rtn1          4.277702379       0.00013212
  A_55_P2159485                  5.254034014       0.00084844   A_51_P501248     Sphk1         4.239981128       6.43E-05
  A_55_P1996973    Gvi n1        5.219003996       0.00589851   A_51_P173709     Gprc5b        4.216740223       0.00086867
  A_30_P01023737                 5.208384457       1.18E-05     A_52_P535484     Gvin1         4.2100439         0.00072863
  A_55_P2071952    Wdr92         5.164057614       1.34E-05     A_55_P2430367    Zbtb8b        4.180203889       4.91E-06
  A_51_P367780     Adamts12      5.153752038       2.08E-05     A_51_P441426     Pf4           4.177619023       0.00022135
  A_52_P120803     Ankrd1        5.150091794       0.00061576   A_30_P01020754                 4.169537934       5.55E-05
  A_52_P220879     Tgm2          5.097421217       0.00035587   A_51_P503625     Gsta3         4.15056312        0.00017442
  A_55_P2185890    Cfh           5.058590753       1.54E-05     A_51_P264695     Crym          4.124721129       0.00368514
  A_55_P1984655    5mtnl2        5.048007589       0.00066022   A_55_P2048855    Sprr2a2       4.10440044        7.57E-06
  A_51_P508838     Kcne4         5.041911898       4.91E-06     A_52_P337259     HeyI          4.0902626         6.83E-06
  A_55_P2107785                  5.02223357        4.56E-05     A_55_P1983858    SeeI          4.076340425       1.99E-05
  A_52_P381484     Spon2         4.995680379       1.40E-06     A_55_P1963463    Gabra3        4.060184936       0.00456924
  A_55_P2017413    Gm4788        4.974910672       4.43E-05     A_55_P1958165    Ms4a7         4.059035938       3.70E-05
  A_55_P1964960    IL13          4.957875799       0.00183759   A_55_P2099742    Ccl19         4.034638511       0.00020569
  A_51_P334942     Aldh1a1       4.930168491       9.06E-07     A_55_P2016237    Hand2         4.024649163       1.76E-06
  A_51_P153423     Fndc1         4.924289787       4.64E-05     A_52_P472302     Fxyd6         4.021862402       5.70E-06
  A_51_P335460     Scin          4.921316898       3.03E-06     A_51_P176352     Ndrg2         4.002251368       0.00037256
  A_55_P2007496                  4.888471012       0.00065309                                                    
  A_52_P796840     Cfhr2         4.807319461       7.84E-06                                                      
  A_51_P246166     Wfdc18        4.794125063       0.00010262                                                    
  A_55_P1998811                  4.74419517        6.38E-05                                                      

###### 

List of differentially expressed entities when comparing cardiac fibroblasts and tail fibroblasts (down-regulated, fold change \<− 16 ×, p \< 0.05).

  Probe ID         Gene symbol     Log fold change   p-Value
  ---------------- --------------- ----------------- ------------
  A_52_P401504     Thbs4           − 9.592174841     1.22E-07
  A_55_P2163033    Hoxb13          − 9.413716631     4.47E-07
  A_51_P152990     Grem2           − 8.848601783     2.76E-08
  A_51_P241068     Dkk2            − 7.605061419     1.48E-06
  A_30_P01024322                   − 6.845383532     0.00167504
  A_51_P339793     111rl1          − 6.624788912     2.97E-06
  A_30_P01022821                   − 6.236747352     8.13E-05
  A_55_P1977431    Cck             − 6.210979682     2.50E-05
  A_55_P2380806    Gm2115          − 6.047107571     1.49E-06
  A_55_P1983754    Pcp411          − 6.022954787     5.01E-06
  A_52_P1092823    lrx1            − 5.709918806     7.44E-07
  A_30_P01017882                   − 5.589314885     3.33E-05
  A_55_P2125311    Rab3b           − 5.524900093     5.71E-07
  A_55_P2104219    Hoxc13          − 5.350209094     1.25E-06
  A_30_P01030354                   − 5.247161242     0.01040968
  A_55_P1963807    Actg2           − 5.05268315      1.23E-06
  A_55_P1959633    Hnf4a           − 5.01046471      0.0084615
  A_51_P431329     Car3            − 4.999183138     0.00029175
  A_55_P2275437                    − 4.971382946     0.0001802
  A_51_P254425     Ah rr           − 4.931766401     1.13E-06
  A_51_P453909     Cyp2f2          − 4.90093426      1.07E-05
  A_52_P547612     Tmem30b         − 4.882588964     3.74E-06
  A_55_P1970075    Hoxa13          − 4.838619293     1.99E-06
  A_30_P01023831                   − 4.836691283     1.42E-06
  A_55_P2035946    Penk            − 4.821628549     4.05E-06
  A_51_P112223     Gsta4           − 4.793332842     1.64E-06
  A_51_P350817     Cnn1            − 4.788691188     1.87E-06
  A_30_P01027398                   − 4.776324333     8.12E-05
  A_55_P2126192    Lgr5            − 4.678393687     0.00126788
  A_51_P309488     1810058N15Ril   − 4.676510147     3.09E-06
  A_51_P253481     Ces1g           − 4.633576905     0.00024964
  A_30_P01019159                   − 4.60457949      3.24E-05
  A_52_P374960     Ostn            − 4.570737399     0.00132575
  A_51_P222337     Rspo2           − 4.566245563     0.00010263
  A_55_P1984896    Fsip2           − 4.54577185      0.00054826
  A_55_P2028399    Hoxc11          − 4.466924796     3.41E-05
  A_55_P2107140    Olfr323         − 4.46213166      6.91E-05
  A_52_P973575     Hoxb9           − 4.442393871     4.66E-05
  A_51_P176202     Ankrd36         − 4.369381912     0.00103598
  A_52_P569375     Fgf5            − 4.365217026     0.00794978
  A_51_P108183     Tnmd            − 4.345146004     0.00198834
  A_51_P194230     Zic1            − 4.320743819     3.29E-05
  A_51_P241319     Cilp            − 4.272317182     0.00206339
  A_51_P413111     Ppm1l           − 4.265754405     3.35E-06
  A_51_P215374     Slc6a17         − 4.220019679     0.00027602
  A_55_P2163659    Rspo3           − 4.177589527     0.00011669
  A_51_P375754     Hoxc10          − 4.165266321     0.00468582
  A_55_P2103297                    − 4.153975645     4.06E-06
  A_55_P2001486                    − 4.137007991     7.49E-05
  A_52_P194971     Hoxb7           − 4.093762326     0.00026535
  A_55_P2360800    C230060E24      − 4.071029277     0.00301094
  A_51_P516637     Bmp5            − 4.058261531     0.00185459
  A_55_P2069226                    − 4.0448526       0.000832
  A_55_P2053933    Foxa1           − 4.04379596      7.51E-05
  A_55_P2014249    Sema3a          − 4.042700618     0.00119229
  A_52_P337126     Bves            − 4.006299        0.00071079

[^1]: Both authors contributed equally to this work.
